tradingkey.logo
tradingkey.logo
検索

Envoy Medical Inc

COCH
ウォッチリストに追加
0.715USD
-0.007-0.97%
取引時間 09/24, 11:22ET
54.97M時価総額
損失額直近12ヶ月PER

Envoy Medical Incについて 企業名

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Envoy Medical Inc プロフィール

企業コードCOCH
会社名Envoy Medical Inc
上場日Mar 02, 2021
最高経営責任者「CEO」Lucas (Brent T)
従業員数42
証券種類Ordinary Share
決算期末Mar 02
本社所在地4875 White Bear Parkway
都市WHITE BEAR LAKE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号55110
電話番号16513618000
ウェブサイトhttps://www.envoymedical.com/
企業コードCOCH
上場日Mar 02, 2021
最高経営責任者「CEO」Lucas (Brent T)

Envoy Medical Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.05M
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.05M
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.05M
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
329.95K
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
329.95K
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
329.95K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
212.50K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
212.50K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Chief Accounting Officer, Vice President - Finance
Chief Accounting Officer, Vice President - Finance
212.50K
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.05M
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.05M
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
1.05M
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
329.95K
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
329.95K
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
329.95K
--

よくある質問

Envoy Medical Incの上位5名の株主は誰ですか?

Envoy Medical Incの上位5名の株主は以下のとおりです。Mr. Charles R. Brynelsen

Envoy Medical Inc(COCH)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Envoy Medical Incの株式を保有している機関は55社あり、保有株式の総市場価値は約1.86Mで、全体の2.42%を占めています。2025Q4と比較して、機関の持ち株は-735506.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。